These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 15627206

  • 1. Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma.
    Arakawa Y, Tachibana O, Hasegawa M, Miyamori T, Yamashita J, Hayashi Y.
    Acta Neuropathol; 2005 Mar; 109(3):294-8. PubMed ID: 15627206
    [Abstract] [Full Text] [Related]

  • 2. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
    Shen HW, Wu YL, Peng SY.
    Zhonghua Yi Xue Za Zhi; 2003 May 10; 83(9):744-7. PubMed ID: 12899749
    [Abstract] [Full Text] [Related]

  • 3. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.
    Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D, Ashkenazi A.
    Nature; 1998 Dec 17; 396(6712):699-703. PubMed ID: 9872321
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.
    Miyanaga T, Hirato J, Nakazato Y.
    Neuropathology; 2008 Apr 17; 28(2):116-26. PubMed ID: 18021194
    [Abstract] [Full Text] [Related]

  • 6. Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.
    Nakamura M, Ishida E, Shimada K, Nakase H, Sakaki T, Konishi N.
    Acta Neuropathol; 2005 Oct 17; 110(4):402-10. PubMed ID: 16155764
    [Abstract] [Full Text] [Related]

  • 7. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival.
    Järvelä S, Helin H, Haapasalo J, Järvelä T, Junttila TT, Elenius K, Tanner M, Haapasalo H, Isola J.
    Neuropathol Appl Neurobiol; 2006 Aug 17; 32(4):441-50. PubMed ID: 16866989
    [Abstract] [Full Text] [Related]

  • 8. Dcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cells.
    Sung HY, Wu HG, Ahn JH, Park WY.
    Int J Radiat Biol; 2010 Sep 17; 86(9):780-90. PubMed ID: 20597837
    [Abstract] [Full Text] [Related]

  • 9. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
    Chang PM, Chen PM, Hsieh SL, Tzeng CH, Liu JH, Chiou TJ, Wang WS, Yen CC, Gau JP, Yang MH.
    Int J Oncol; 2008 Sep 17; 33(3):549-54. PubMed ID: 18695885
    [Abstract] [Full Text] [Related]

  • 10. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
    Hayashi S, Miura Y, Nishiyama T, Mitani M, Tateishi K, Sakai Y, Hashiramoto A, Kurosaka M, Shiozawa S, Doita M.
    Arthritis Rheum; 2007 Apr 17; 56(4):1067-75. PubMed ID: 17393415
    [Abstract] [Full Text] [Related]

  • 11. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B, Autschbach F, Kim S, Lasitschka F, Strauch U, Rogler G, Gdynia G, Li L, Gretz N, Macher-Goeppinger S, Sido B, Schirmacher P, Meuer SC, Roth W.
    Gut; 2009 Apr 17; 58(4):483-91. PubMed ID: 19039087
    [Abstract] [Full Text] [Related]

  • 12. The gene for the axonal cell adhesion molecule TAX-1 is amplified and aberrantly expressed in malignant gliomas.
    Rickman DS, Tyagi R, Zhu XX, Bobek MP, Song S, Blaivas M, Misek DE, Israel MA, Kurnit DM, Ross DA, Kish PE, Hanash SM.
    Cancer Res; 2001 Mar 01; 61(5):2162-8. PubMed ID: 11280781
    [Abstract] [Full Text] [Related]

  • 13. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas.
    Takahama Y, Yamada Y, Emoto K, Fujimoto H, Takayama T, Ueno M, Uchida H, Hirao S, Mizuno T, Nakajima Y.
    Gastric Cancer; 2002 Mar 01; 5(2):61-8. PubMed ID: 12111580
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis.
    Shen HW, Gao SL, Wu YL, Peng SY.
    World J Gastroenterol; 2005 Oct 14; 11(38):5926-30. PubMed ID: 16273601
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of decoy receptor 3 in precancerous lesions and adenocarcinoma of the esophagus.
    Li H, Zhang L, Lou H, Ding I, Kim S, Wang L, Huang J, Di Sant'Agnese PA, Lei JY.
    Am J Clin Pathol; 2005 Aug 14; 124(2):282-7. PubMed ID: 16040301
    [Abstract] [Full Text] [Related]

  • 16. Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors.
    Ellert-Miklaszewska A, Grajkowska W, Gabrusiewicz K, Kaminska B, Konarska L.
    Brain Res; 2007 Mar 16; 1137(1):161-9. PubMed ID: 17239827
    [Abstract] [Full Text] [Related]

  • 17. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma.
    Tsuji S, Hosotani R, Yonehara S, Masui T, Tulachan SS, Nakajima S, Kobayashi H, Koizumi M, Toyoda E, Ito D, Kami K, Mori T, Fujimoto K, Doi R, Imamura M.
    Int J Cancer; 2003 Aug 10; 106(1):17-25. PubMed ID: 12794752
    [Abstract] [Full Text] [Related]

  • 18. Correlation between expression of DcR3 on tumor cells and sensitivity to FasL.
    Li W, Zhang C, Chen C, Zhuang G.
    Cell Mol Immunol; 2007 Dec 10; 4(6):455-60. PubMed ID: 18163957
    [Abstract] [Full Text] [Related]

  • 19. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
    Mishima K, Kato Y, Kaneko MK, Nishikawa R, Hirose T, Matsutani M.
    Acta Neuropathol; 2006 May 10; 111(5):483-8. PubMed ID: 16596424
    [Abstract] [Full Text] [Related]

  • 20. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors.
    Fleming TP, Saxena A, Clark WC, Robertson JT, Oldfield EH, Aaronson SA, Ali IU.
    Cancer Res; 1992 Aug 15; 52(16):4550-3. PubMed ID: 1322795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.